Cite
APA Citation
Vanover, K., Glass, S., Kozauer, S., Saillard, J., Sanchez, J., Weingart, M., Mates, S., Satlin, A., & Davis, R. (n.d.). 30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study. CNS spectrums, 24, 190–191. http://access.bl.uk/ark:/81055/vdc_100078550803.0x000020